SKINVIVE by JUVÉDERM, a hyaluronic acid filler, has gained FDA clearance for treatment of neck lines—a new indication that expands the addressable market beyond the face. The product is formulated with JUVÉDERM's proprietary cross-linking technology and is designed for superficial dermal placement to improve skin quality and fine lines in the neck and décolletage region.
Injectables
SKINVIVE Neck-Line Indication Expands Filler Market
FDA-approved JUVÉDERM product now marketed for neck lines, opening new treatment area.
Neck/décolletage aesthetics represent a high-margin, under-penetrated treatment area.
This indication matters because neck/décolletage aesthetics represent a high-margin, under-penetrated treatment area in most practices. Patients seeking facial rejuvenation often neglect the neck, creating an upsell opportunity. The approval also positions JUVÉDERM against Restylane and Belotero in the neck-specific filler category, where clinical data supporting safety and longevity remain sparse. Practices should train injectors on placement depth and volume to avoid Tyndall effect and ensure patient satisfaction.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.